Chip-in-a-pill may be approved in 2012

(PhysOrg.com) -- Giant Swiss pharmaceutical company Novartis AG, based in Basel, is developing a pill containing an embedded microchip, which it hopes to submit for regulatory approval in Europe within 18 months. The chip is activated by the stomach acid, and transmits information to a patch attached to the patient's skin, which then sends it on to a doctor via the Internet or a smartphone.

Read the whole article on Physorg

More from Physorg